Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells

Published:2011-11-14 Issue:2 Volume:92 Page:178-190
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Attar-Schneider Oshrat,Drucker Liat,Zismanov Victoria,Tartakover-Matalon Shelly,Rashid Gloria,Lishner Michael

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest2011162.pdf

Reference48 articles.

1. Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet 2009;374:324–339.

2. Lentzch S, Chatterjee M, Gries M, et al. PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 2004;18:1883–1890.

3. Kumar S, Witzig TE, Timm M, et al. Expression of VEGF and its receptors by myeloma cells. Leukemia 2003;17:2025–2031.

4. Vincent L, Jin DK, Karajannis MA, et al. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells. Cancer Res 2005;65:3185–3192.

5. Frost P, Shi Y, Lichtenstein A . Akt activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells. Oncogene 2007;26:2255–2262.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy;Cell Communication and Signaling;2024-06-11

2. Targeted immunotherapy: harnessing the immune system to battle multiple myeloma;Cell Death Discovery;2024-01-27

3. Autophagy-related mechanisms for treatment of multiple myeloma;Cancer Drug Resistance;2023-12-25

4. Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects;Blood Advances;2023-06-27

5. Anti-Angiogenic Activity of Drugs in Multiple Myeloma;Cancers;2023-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3